Literature DB >> 24406291

Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Yvonne Collins1, Kevin Holcomb2, Eloise Chapman-Davis3, Dineo Khabele4, John H Farley5.   

Abstract

OBJECTIVES: To review the extent of health disparities in gynecologic cancer care and outcomes and to propose recommendations to help counteract the disparities.
METHODS: We searched the electronic databases PubMed and the Cochrane Library. We included studies demonstrating quantifiable differences by race and ethnicity in the incidence, treatment, and survival of gynecologic cancers in the United States (US). Most studies relied on retrospective data. We focused on differences between Black and White women, because of the limited number of studies on non-Black women.
RESULTS: White women have a higher incidence of ovarian cancer compared to Black women. However, the all-cause ovarian cancer mortality in Black women is 1.3 times higher than that of White women. Endometrial and cervical cancer mortality in Black women is twice that of White women. The etiology of these disparities is multifaceted. However, much of the evidence suggests that equal care leads to equal outcomes for Black women diagnosed with gynecologic cancers. Underlying molecular factors may play an additional role in aggressive tumor biology and endometrial cancer disparities.
CONCLUSION: Gynecologic cancer disparities exist between Black and White women. The literature is limited by the lack of large prospective trials and adequate numbers of non-Black racial and ethnic groups. We conclude with recommendations for continued research and a multifaceted approach to eliminate gynecologic cancer disparities.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical; Disparities; Endometrial and ovarian cancers; Ethnic; Gynecologic cancer; Racial

Mesh:

Year:  2014        PMID: 24406291      PMCID: PMC4079541          DOI: 10.1016/j.ygyno.2013.12.039

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  70 in total

1.  Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study.

Authors:  Veronica Wendy Setiawan; Malcolm C Pike; Laurence N Kolonel; Abraham M Nomura; Marc T Goodman; Brian E Henderson
Journal:  Am J Epidemiol       Date:  2006-11-07       Impact factor: 4.897

Review 2.  Racial and ethnic disparities in cancers of the uterine corpus.

Authors:  O W Stephanie Yap; Roland P Matthews
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

3.  Addressing racial and ethnic disparities in health care.

Authors:  Richard B Gunderman
Journal:  Radiology       Date:  2007-07       Impact factor: 11.105

4.  Association of lymphadenectomy and survival in stage I ovarian cancer patients.

Authors:  John K Chan; Elizabeth G Munro; Michael K Cheung; Amreen Husain; Nelson N Teng; Jonathan S Berek; Kathryn Osann
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

5.  Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.

Authors:  G L Maxwell; J I Risinger; K A Hayes; A A Alvarez; R K Dodge; J C Barrett; A Berchuck
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

6.  Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors:  G Larry Maxwell; Chunqiao Tian; John Risinger; Carol L Brown; G Scott Rose; J Tate Thigpen; Gini F Fleming; Holly H Gallion; Wendy R Brewster
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

7.  Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Authors:  William E Winter; G Larry Maxwell; Chunqiao Tian; Jay W Carlson; Robert F Ozols; Peter G Rose; Maurie Markman; Deborah K Armstrong; Franco Muggia; William P McGuire
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

8.  Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.

Authors:  John K Chan; Mallory Zhang; Jessica M Hu; Jacob Y Shin; Kathryn Osann; Daniel S Kapp
Journal:  J Surg Oncol       Date:  2008-02-01       Impact factor: 3.454

Review 9.  Role of surgery in ovarian carcinoma.

Authors:  Amanda Nickles Fader; Peter G Rose
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

10.  Predictors of comprehensive surgical treatment in patients with ovarian cancer.

Authors:  Barbara A Goff; Barbara J Matthews; Eric H Larson; C Holly A Andrilla; Michelle Wynn; Denise M Lishner; Laura-Mae Baldwin
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

View more
  63 in total

1.  Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors.

Authors:  Lacey Loomer; Kevin C Ward; Evelyn A Reynolds; Silke A von Esenwein; Joseph Lipscomb
Journal:  J Cancer Surviv       Date:  2019-06-06       Impact factor: 4.442

2.  Surgical wait time: A new health indicator in women with endometrial cancer.

Authors:  Anna E Strohl; Joseph M Feinglass; Shohreh Shahabi; Melissa A Simon
Journal:  Gynecol Oncol       Date:  2016-04-23       Impact factor: 5.482

3.  Reactive Oxygen Species and Serous Epithelial Ovarian Adenocarcinoma.

Authors:  Shakeria Cohen; Sharifeh Mehrabi; Xuebiao Yao; Stephanie Millingen; Felix O Aikhionbare
Journal:  Cancer Res J (N Y N Y)       Date:  2017-01-09

4.  The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries.

Authors:  Paul C Pearlman; Rao Divi; Michael Gwede; Pushpa Tandon; Brian S Sorg; Miguel R Ossandon; Lokesh Agrawal; Vinay Pai; Houston Baker; Tiffani Bailey Lash
Journal:  IEEE J Transl Eng Health Med       Date:  2016-09-08       Impact factor: 3.316

5.  Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes.

Authors:  Hyo K Park; Julie J Ruterbusch; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-27       Impact factor: 4.254

6.  The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer.

Authors:  T Clark Powell; Sarah E Dilley; Sejong Bae; J Michael Straughn; Kenneth H Kim; Charles A Leath
Journal:  J Low Genit Tract Dis       Date:  2018-10       Impact factor: 1.925

7.  Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes.

Authors:  Tomi F Akinyemiju; Gurudatta Naik; Kemi Ogunsina; Daniel T Dibaba; Neomi Vin-Raviv
Journal:  Cancer Causes Control       Date:  2018-02-10       Impact factor: 2.506

8.  Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Authors:  Dana Whittemore; Lili Ding; Lea E Widdice; Darron A Brown; David I Bernstein; Eduardo L Franco; Jessica A Kahn
Journal:  J Womens Health (Larchmt)       Date:  2016-10-18       Impact factor: 2.681

9.  Physical activity barriers and resources among black women with a history of breast and endometrial cancer: a systematic review.

Authors:  Natasha R Burse; Nishat Bhuiyan; Scherezade K Mama; Kathryn H Schmitz
Journal:  J Cancer Surviv       Date:  2020-04-02       Impact factor: 4.442

10.  Pharmacological Effects of Natural Components Against Ovarian Cancer and Mechanisms.

Authors:  Huidi Liu; Shu-Lin Liu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.